CGON

NASDAQ · Biotechnology

Cg Oncology Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$75.99

+11.19 (+17.27%)

As of Nov 7, 1:31 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target -52.7% upside

Low Target $23.54

Average Target $35.94

High Target $41.91

Current Price $75.99

Current
$75.99

Target
$35.94

$23.54 $35.94 avg $41.91

Scenario Analysis

Bear Case

$23.54

-69.0%

Low target

Base Case

$35.94

-52.7%

Avg target

Bull Case

$41.91

+-44.8%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$80.97

-6.2% from high

52-Week Low

$35.80

+112.3% from low

50-Day SMA

$68.24

+11.4% vs SMA

200-Day SMA

$66.20

+14.8% vs SMA

RSI (14)

76.5

Overbought

Target vs 52W High

$35.94

-55.6% vs high

Next Earnings Report

Nov 12, 2026

until earnings

EPS Est: $-0.86

Earnings in 4 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%